Fortress Biotech, Inc. Sustainability Profile
Fortress Biotech, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2010, the company focuses on developing and commercialising innovative therapies for rare and complex diseases. With a robust portfolio of products, Fortress Biotech stands out for its unique approach to drug development, leveraging its extensive network of subsidiaries and partnerships to enhance its market position. The company operates primarily in the fields of oncology and rare diseases, with a commitment to addressing unmet medical needs. Notable achievements include the successful advancement of several drug candidates through clinical trials, showcasing its dedication to innovation and patient care. Fortress Biotech continues to solidify its reputation as a leader in the biopharmaceutical sector, driven by a mission to improve patient outcomes through cutting-edge therapies.
DitchCarbon Score
How does Fortress Biotech, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fortress Biotech, Inc.'s score of 25 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fortress Biotech, Inc.'s reported carbon emissions
Fortress Biotech, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Fortress Biotech has not inherited any emissions data from a parent or related organization, and there are no commitments to industry-standard initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the biotechnology industry, companies are increasingly focusing on sustainability and climate commitments. However, without specific data or targets, Fortress Biotech's current stance on carbon emissions and climate action remains unclear.
How Carbon Intensive is Fortress Biotech, Inc.'s Industry?
How Carbon Intensive is Fortress Biotech, Inc.'s Location?
Fortress Biotech, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fortress Biotech, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
